Reckitt Benckiser Group plc (ETR:3RB0)
Germany · Delayed Price · Currency is EUR | Market Cap | 33.40B -12.3% |
| Revenue (ttm) | 16.28B -0.9% |
| Net Income | 3.65B +106.1% |
| EPS | 5.58 +116.1% |
| Shares Out | n/a |
| PE Ratio | 9.16 |
| Forward PE | 13.53 |
| Dividend | 5.19 (9.69%) |
| Ex-Dividend Date | Apr 9, 2026 |
| Volume | 20,483 |
| Average Volume | 16,847 |
| Open | 53.34 |
| Previous Close | 53.52 |
| Day's Range | 52.96 - 53.52 |
| 52-Week Range | 52.64 - 75.04 |
| Beta | n/a |
| RSI | 34.53 |
| Earnings Date | Jul 29, 2026 |
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under... [Read more]
Financial Performance
In 2025, Reckitt Benckiser Group's revenue was 14.21 billion, an increase of 0.25% compared to the previous year's 14.17 billion. Earnings were 3.18 billion, an increase of 123.14%.
Financial numbers in GBP Financial StatementsNews
Reckitt Benckiser price target lowered to 6,200 GBp from 7,000 GBp at Citi
Citi lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 6,200 GBp from 7,000 GBp and keeps a Buy rating on the shares.
Reckitt stock dips on Q1 miss: what's really ailing the health giant?
Reckitt stock fell about 5% in early trading on Wednesday after the consumer goods group said first-quarter core like-for-like net revenue rose only 1.3%. The figure was well below the 2.9% analysts h...
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance
Lysol maker Reckitt Benckiser booked a rise in first-quarter like for like revenue, helped by strong emerging markets performance, where like-for-like sales grew 7.6%.
Reckitt misses revenue forecast, warns on margins on oil price shock
Reckitt missed quarterly like-for-like revenue forecasts and warned of lower first-half margins, citing high oil prices and a weak cold and flu season, knocking the Dettol maker's shares as much as 7...
Reckitt Benckiser upgraded to Buy from Hold at Kepler Cheuvreux
Kepler Cheuvreux analyst Karel Zoete upgraded Reckitt Benckiser (RBGLY) to Buy from Hold with a 6,000 GBp price target The firm views the post-earnings selloff as overdone. Published first on…
Reckitt Benckiser price target lowered to 6,200 GBp at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 6,200 GBp from 6,300 GBp and keeps an Overweight rating on the shares.
Reckitt Benckiser price target lowered to 5,460 GBp at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 5,460 GBp from 5,500 GBp and keeps a Hold rating on the shares.
Reckitt Benckiser upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley upgraded Reckitt Benckiser (RBGLY) to Overweight from Equal Weight with a price target of 6,300 GBp, down from 6,500 GBp. The firm says the current share price does…
Reckitt Benckiser price target lowered to 5,479 GBp from 5,647 GBp at Berenberg
Berenberg lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 5,479 GBp from 5,647 GBp and keeps a Hold rating on the shares.
Reckitt Benckiser price target lowered to 5,800 GBp from 6,100 GBp at JPMorgan
JPMorgan lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 5,800 GBp from 6,100 GBp and keeps a Neutral rating on the shares.
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets
The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.
Reckitt Benckiser downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Reckitt Benckiser (RBGLY) to Sector Perform from Outperform with a price target of 6,200 GBp, down from 6,400 GBp. The firm cites valuation following the disposal of…
Reckitt Benckiser reinstated with a Buy at Citi
Citi analyst Cedric Besnard reinstated coverage of Reckitt Benckiser (RBGLY) with a Buy rating and 7,000 GBp price target The firm says the shares still offer “the right defensive catalyst…
Reckitt Benckiser price target raised to 5,900 GBp from 5,500 GBp at Jefferies
Jefferies raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,900 GBp from 5,500 GBp and keeps a Hold rating on the shares. The firm updated its view of…
Reckitt Benckiser downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Reckitt Benckiser (RBGLY) to Equal Weight from Overweight with an unchanged price target of 6,100 GBp. The firm sees the stock’s risk/reward as more balanced at current…
Avatars, influencers in China livestreams help drive Reckitt's emerging-market led growth
Influencers and AI-generated avatars selling everything from Durex condoms to Harpic toilet cleaner on livestreaming apps in China are propelling emerging-market led growth for consumer goods company ...
Reckitt Benckiser price target raised to 5,647 GBp from 5,555 GBp at Berenberg
Berenberg raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,647 GBp from 5,555 GBp and keeps a Hold rating on the shares.
Reckitt Benckiser price target raised to 5,700 GBp at Deutsche Bank
Deutsche Bank raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,700 GBp from 5,600 GBp and keeps a Hold rating on the shares.
Reckitt Benckiser price target raised to 6,400 GBp at RBC Capital
RBC Capital analyst James Edwardes Jones raised the firm’s price target on Reckitt Benckiser (RBGLY) to 6,400 GBp from 6,000 GBp and keeps an Outperform rating on the shares. Published…
Reckitt Benckiser Logs Higher Sales as Consumers Spend on Self-Care
Sales grew 7% on a like-for-like basis, lifted by consumer spending on self-care, germ-protection and sexual-health products.
Reckitt Benckiser price target lowered to 5,555 GBp from 5,920 GBp at Berenberg
Berenberg lowered the firm’s price target on Reckitt Benckiser (RBGLY) to 5,555 GBp from 5,920 GBp and keeps a Hold rating on the shares.
Metaguest.AI Begins Trading on OTCQB Venture Market, Provides Financing Update, and Announces Investor Forum on August 7
TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Metaguest.AI Incorporated (CSE: METG) (OTCQB:MGSTF) (“Metaguest” or the “Company”) an AI technology company transforming the hospitality sector through intel...
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo...
President Trump demands drugmakers slash prices within 60 days
CNBC's Joe Kernen reports on the latest news.
Reckitt Benckiser price target raised to 5,600 GBp at Deutsche Bank
Deutsche Bank raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,600 GBp from 5,300 GBp and keeps a Hold rating on the shares.